Follow
Douglas Lorne Arnold, MD, FRCP(C)
Douglas Lorne Arnold, MD, FRCP(C)
James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill
Verified email at mcgill.ca - Homepage
Title
Cited by
Cited by
Year
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
27682008
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
20482012
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
N Engl J Med 376 (3), 209-220, 2017
19262017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
N Engl J Med 376 (3), 221-234, 2017
18492017
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ...
The Lancet 380 (9856), 1819-1828, 2012
12712012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ...
The lancet 380 (9856), 1829-1839, 2012
12612012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ...
Lancet 391 (10127), 1263-1273, 2018
9852018
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ...
Nature medicine 2 (3), 1996
6721996
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability
N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ...
Archives of neurology 58 (1), 65-70, 2001
6712001
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study
N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ...
Brain 121 (Pt 8), 1469-1477, 1998
6171998
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
6022008
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ...
Brain 121 (1), 103-113, 1998
6001998
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region
N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ...
Brain 126 (2), 462-469, 2003
5812003
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR
DL Arnold, PM Matthews, GK Radda
Magnetic resonance in medicine 1 (3), 307-315, 1984
5721984
Reversible decreases in N‐acetylaspartate after acute brain injury
ND Stefano, PM Matthews, DL Arnold
Magnetic Resonance in Medicine 34 (5), 721-727, 1995
5301995
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation
AT Nair T, Precup D, Arnold DL
Med Image Anal 59, 101557, 2020
4592020
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ...
The Lancet Neurology 13 (7), 657-665, 2014
4572014
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging
D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins
Medical image analysis 17 (1), 1-18, 2013
4432013
Incidence of acquired demyelination of the CNS in Canadian children
B Banwell, J Kennedy, D Sadovnick, DL Arnold, S Magalhaes, ...
Neurology 72 (3), 232-239, 2009
4032009
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
B Banwell, A Bar-Or, DL Arnold, D Sadovnick, S Narayanan, M McGowan, ...
The Lancet Neurology 10 (5), 436-445, 2011
3982011
The system can't perform the operation now. Try again later.
Articles 1–20